JP2013541697A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013541697A5 JP2013541697A5 JP2013525961A JP2013525961A JP2013541697A5 JP 2013541697 A5 JP2013541697 A5 JP 2013541697A5 JP 2013525961 A JP2013525961 A JP 2013525961A JP 2013525961 A JP2013525961 A JP 2013525961A JP 2013541697 A5 JP2013541697 A5 JP 2013541697A5
- Authority
- JP
- Japan
- Prior art keywords
- individual
- biomarker
- pancreatic cancer
- information corresponding
- pancreatic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 37
- 239000000090 biomarker Substances 0.000 claims 35
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 21
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 21
- 201000002528 pancreatic cancer Diseases 0.000 claims 21
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 21
- 238000004458 analytical method Methods 0.000 claims 12
- 239000012472 biological sample Substances 0.000 claims 7
- 238000000338 in vitro Methods 0.000 claims 5
- 108090000623 proteins and genes Proteins 0.000 claims 5
- 102000004169 proteins and genes Human genes 0.000 claims 5
- 108091023037 Aptamer Proteins 0.000 claims 4
- 239000003153 chemical reaction reagent Substances 0.000 claims 4
- 230000002380 cytological effect Effects 0.000 claims 4
- 210000004923 pancreatic tissue Anatomy 0.000 claims 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 3
- 230000000391 smoking effect Effects 0.000 claims 3
- 206010000077 Abdominal mass Diseases 0.000 claims 2
- 102100022524 Alpha-1-antichymotrypsin Human genes 0.000 claims 2
- 102100036850 C-C motif chemokine 23 Human genes 0.000 claims 2
- 102100021633 Cathepsin B Human genes 0.000 claims 2
- 102100040898 Growth/differentiation factor 11 Human genes 0.000 claims 2
- 102100036284 Hepcidin Human genes 0.000 claims 2
- 101000678026 Homo sapiens Alpha-1-antichymotrypsin Proteins 0.000 claims 2
- 101000713081 Homo sapiens C-C motif chemokine 23 Proteins 0.000 claims 2
- 101000898449 Homo sapiens Cathepsin B Proteins 0.000 claims 2
- 101000893545 Homo sapiens Growth/differentiation factor 11 Proteins 0.000 claims 2
- 101001021253 Homo sapiens Hepcidin Proteins 0.000 claims 2
- 101000990912 Homo sapiens Matrilysin Proteins 0.000 claims 2
- 101001091365 Homo sapiens Plasma kallikrein Proteins 0.000 claims 2
- 101000605534 Homo sapiens Prostate-specific antigen Proteins 0.000 claims 2
- 101000633617 Homo sapiens Thrombospondin-4 Proteins 0.000 claims 2
- 102100030417 Matrilysin Human genes 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 102100034869 Plasma kallikrein Human genes 0.000 claims 2
- 102100029219 Thrombospondin-4 Human genes 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 238000003745 diagnosis Methods 0.000 claims 2
- 238000003018 immunoassay Methods 0.000 claims 2
- 210000001819 pancreatic juice Anatomy 0.000 claims 2
- 210000002381 plasma Anatomy 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 1
- 206010049082 Pancreatic mass Diseases 0.000 claims 1
- 206010033645 Pancreatitis Diseases 0.000 claims 1
- 230000000711 cancerogenic effect Effects 0.000 claims 1
- 231100000357 carcinogen Toxicity 0.000 claims 1
- 239000003183 carcinogenic agent Substances 0.000 claims 1
- 238000003748 differential diagnosis Methods 0.000 claims 1
- 230000014509 gene expression Effects 0.000 claims 1
- 230000002068 genetic effect Effects 0.000 claims 1
- 238000009533 lab test Methods 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37368710P | 2010-08-13 | 2010-08-13 | |
| US61/373,687 | 2010-08-13 | ||
| US41868910P | 2010-12-01 | 2010-12-01 | |
| US61/418,689 | 2010-12-01 | ||
| US201161482480P | 2011-05-04 | 2011-05-04 | |
| US201161482347P | 2011-05-04 | 2011-05-04 | |
| US61/482,347 | 2011-05-04 | ||
| US61/482,480 | 2011-05-04 | ||
| PCT/US2011/047570 WO2012021795A2 (en) | 2010-08-13 | 2011-08-12 | Pancreatic cancer biomarkers and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013541697A JP2013541697A (ja) | 2013-11-14 |
| JP2013541697A5 true JP2013541697A5 (enExample) | 2014-09-18 |
| JP5931874B2 JP5931874B2 (ja) | 2016-06-08 |
Family
ID=45565264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013525961A Expired - Fee Related JP5931874B2 (ja) | 2010-08-13 | 2011-08-12 | 膵癌バイオマーカーおよびその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20120040861A1 (enExample) |
| EP (1) | EP2603622A4 (enExample) |
| JP (1) | JP5931874B2 (enExample) |
| KR (1) | KR101857462B1 (enExample) |
| CN (2) | CN103415624B (enExample) |
| AU (3) | AU2011289284B2 (enExample) |
| BR (1) | BR112013003391B8 (enExample) |
| CA (1) | CA2804857C (enExample) |
| IL (1) | IL224014A (enExample) |
| MX (2) | MX341517B (enExample) |
| SG (3) | SG10201710447QA (enExample) |
| WO (1) | WO2012021795A2 (enExample) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10359425B2 (en) * | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| MX355020B (es) | 2010-07-09 | 2018-04-02 | Somalogic Inc | Biomarcadores de cancer de pulmon y usos de los mismos. |
| JP5931874B2 (ja) | 2010-08-13 | 2016-06-08 | ソマロジック・インコーポレーテッド | 膵癌バイオマーカーおよびその使用 |
| NL2009015C2 (en) * | 2012-04-10 | 2013-10-15 | Biosparq B V | Method for classification of a sample on the basis of spectral data, method for creating a database and method for using this database, and corresponding computer program, data storage medium and system. |
| CA2902841A1 (en) * | 2013-03-13 | 2014-10-02 | Creatics Llc | Methods and compositions for detecting pancreatic cancer |
| WO2014159797A1 (en) * | 2013-03-14 | 2014-10-02 | Abbott Molecular Inc. | Cell preparations and cell supports and their use in theranosis |
| CN103310105A (zh) * | 2013-06-13 | 2013-09-18 | 浙江加州国际纳米技术研究院绍兴分院 | 筛选非小细胞肺癌治疗疗效生物标记物的方法 |
| CN103324846A (zh) * | 2013-06-13 | 2013-09-25 | 浙江加州国际纳米技术研究院绍兴分院 | 结直肠癌症治疗预后生物标记物的筛选方法 |
| CA2952390A1 (en) * | 2013-06-20 | 2014-12-24 | The Trustees Of The University Of Pennsylvania | Methods for diagnosing pancreatic cancer |
| KR101594981B1 (ko) * | 2013-10-31 | 2016-02-17 | 에스케이텔레콤 주식회사 | 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법 |
| WO2015065097A1 (ko) * | 2013-10-31 | 2015-05-07 | 에스케이텔레콤 주식회사 | 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법 |
| KR101594980B1 (ko) * | 2013-10-31 | 2016-02-17 | 에스케이텔레콤 주식회사 | 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법 |
| KR20150129932A (ko) * | 2014-05-12 | 2015-11-23 | 연세대학교 산학협력단 | 보체인자 b 단백질에 특이적으로 결합하는 항체를 포함하는 췌장암 진단용 키트 |
| US9885718B2 (en) | 2014-07-02 | 2018-02-06 | Dragon Victory Development Ltd. | Specific biomarker set for non-invasive diagnosis of liver cancer |
| US9506925B2 (en) | 2014-07-02 | 2016-11-29 | Dragon Victory Development Ltd. | Specific biomarker set for non-invasive diagnosis of liver cancer |
| KR20160045547A (ko) | 2014-10-17 | 2016-04-27 | 에스케이텔레콤 주식회사 | 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법 |
| WO2016060382A1 (ko) * | 2014-10-17 | 2016-04-21 | 에스케이텔레콤 주식회사 | 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법 |
| WO2016094330A2 (en) * | 2014-12-08 | 2016-06-16 | 20/20 Genesystems, Inc | Methods and machine learning systems for predicting the liklihood or risk of having cancer |
| JP2016214239A (ja) * | 2015-05-15 | 2016-12-22 | 国立大学法人高知大学 | 膵がんマーカー |
| CN108138238A (zh) * | 2015-07-28 | 2018-06-08 | 约翰霍普金斯大学 | 用于检测胰腺癌的组合物和方法 |
| WO2017044715A1 (en) * | 2015-09-09 | 2017-03-16 | Somalogic, Inc. | Methods for developing personalized drug treatment plans and targeted drug development based on proteomic profiles |
| EP3373820B1 (en) * | 2015-11-10 | 2024-09-11 | Exact Imaging Inc. | A system comprising indicator features in high-resolution micro-ultrasound images |
| JP6498107B2 (ja) * | 2015-11-30 | 2019-04-10 | 日本電信電話株式会社 | 分類装置、方法、及びプログラム |
| US20210215711A1 (en) * | 2016-02-08 | 2021-07-15 | Somalogic, Inc. | Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Biomarkers and Uses Thereof |
| GB201608192D0 (en) * | 2016-05-10 | 2016-06-22 | Immunovia Ab | Method, array and use thereof |
| EP3458992B1 (en) * | 2016-05-19 | 2022-03-02 | Quartz Bio SA | Biomarkers signature discovery and selection |
| JP7057913B2 (ja) | 2016-06-09 | 2022-04-21 | 株式会社島津製作所 | ビッグデータ解析方法及び該解析方法を利用した質量分析システム |
| EP3532985B1 (en) * | 2016-10-28 | 2023-07-12 | Beckman Coulter, Inc. | Substance preparation evaluation system |
| CA3054571A1 (en) | 2017-02-24 | 2018-08-30 | Board Of Regents,The University Of Texas System | Assay for detection of early stage pancreatic cancer |
| CN108931650A (zh) * | 2017-05-24 | 2018-12-04 | 宜昌市中心人民医院 | 一种激肽释放酶7在血液中的活性检测方法及其作为诊断胰腺癌的血清标志物上的应用 |
| CN108931651A (zh) * | 2017-05-24 | 2018-12-04 | 宜昌市中心人民医院 | 一种激肽释放酶7在血液中的含量检测方法及其作为诊断胰腺癌的血清标志物上的应用 |
| US20200249235A1 (en) * | 2017-07-07 | 2020-08-06 | The Trustees Of The University Of Pennsylvania | Methods for diagnosing pancreatic cancer |
| US11062792B2 (en) * | 2017-07-18 | 2021-07-13 | Analytics For Life Inc. | Discovering genomes to use in machine learning techniques |
| US11139048B2 (en) | 2017-07-18 | 2021-10-05 | Analytics For Life Inc. | Discovering novel features to use in machine learning techniques, such as machine learning techniques for diagnosing medical conditions |
| CN107389776B (zh) * | 2017-07-18 | 2020-06-02 | 宁波瑞瑧生物科技有限公司 | 一种用于检测药物分布的分析方法及其应用 |
| KR101830314B1 (ko) | 2017-07-26 | 2018-02-20 | 재단법인 구미전자정보기술원 | 인공지능 기반 베이지안 네트워크를 이용한 췌장암 진단에 필요한 정보제공 방법, 컴퓨터 프로그램 및 컴퓨터 판독 가능한 기록 매체 |
| CN109425739B (zh) * | 2017-08-31 | 2022-03-18 | 复旦大学 | 一组蛋白作为肿瘤标志物在制备恶性肿瘤诊断试剂和试剂盒中的用途 |
| US11961595B2 (en) * | 2018-01-30 | 2024-04-16 | Sri International | Computational generation of chemical synthesis routes and methods |
| JP7455757B2 (ja) * | 2018-04-13 | 2024-03-26 | フリーノーム・ホールディングス・インコーポレイテッド | 生体試料の多検体アッセイのための機械学習実装 |
| US12416636B2 (en) | 2018-05-31 | 2025-09-16 | University Of Florida Research Foundation, Inc. | Personalized treatment of pancreatic cancer |
| US20210181188A1 (en) * | 2018-08-24 | 2021-06-17 | The Regents Of The University Of California | Mhc-ii genotype restricts the oncogenic mutational landscape |
| JP2022501033A (ja) * | 2018-09-19 | 2022-01-06 | ブルースター ジェノミクス， インコーポレイテッド | 膵臓病変の評価における無細胞ｄｎａヒドロキシメチル化プロファイル |
| CN109919688B (zh) * | 2019-03-29 | 2021-03-05 | 杭州电子科技大学 | 一种考虑市场因素的电子烟产品线规划方法 |
| EP3959341B1 (en) * | 2019-04-22 | 2025-10-15 | Orbit Genomics, Inc. | Methods and systems for microsatellite analysis |
| EP3959719A4 (en) * | 2019-04-26 | 2022-06-01 | Sean Kelly | DEVICE FOR PERSONAL PREDICTIVE ENRICHMENT OF A BIOMARKER AND METHODS OF USING IT |
| CN111584010B (zh) * | 2020-04-01 | 2022-05-27 | 昆明理工大学 | 一种基于胶囊神经网络和集成学习的关键蛋白质识别方法 |
| WO2023282916A1 (en) | 2021-07-09 | 2023-01-12 | Guardant Health, Inc. | Methods of detecting genomic rearrangements using cell free nucleic acids |
| EP4179111B1 (en) | 2020-07-10 | 2024-04-03 | Guardant Health, Inc. | Methods of detecting genomic rearrangements using cell free nucleic acids |
| US20230368915A1 (en) * | 2020-09-10 | 2023-11-16 | Caris Mpi, Inc. | Metastasis predictor |
| CN114250298B (zh) * | 2020-09-23 | 2024-09-24 | 中国医学科学院北京协和医院 | 胰腺导管腺癌的dna甲基化标志物及其应用 |
| WO2022139465A1 (ko) * | 2020-12-22 | 2022-06-30 | 두에이아이(주) | 인공지능 라만 분석 기법을 이용한 췌장암 조기진단 방법 |
| EP4327098A1 (en) * | 2021-04-21 | 2024-02-28 | Reccan Diagnostics AB | Pancreatic cancer detection |
| CN113096125B (zh) * | 2021-05-11 | 2024-05-31 | 上海宝藤生物医药科技股份有限公司 | 低密度脂蛋白试剂浓度的确定方法、装置及存储介质 |
| AU2022399828A1 (en) * | 2021-11-30 | 2024-05-23 | Venn Biosciences Corporation | Diagnosis of pancreatic cancer using targeted quantification of site-specific protein glycosylation |
| WO2023196571A1 (en) * | 2022-04-08 | 2023-10-12 | The Johns Hopkins University | Machine learning detection of hypermetabolic cancer based on nuclear magnetic resonance spectra |
| CN119403940A (zh) * | 2022-06-10 | 2025-02-07 | 希望之城 | 胰腺癌中的生物标志物 |
| KR102651556B1 (ko) * | 2022-09-28 | 2024-03-27 | 주식회사 휴벳바이오 | Ca19-9 수준이 낮은 환자의 췌장암 진단용 조성물 |
| WO2024192491A1 (pt) * | 2023-03-23 | 2024-09-26 | Huna Ltda. | Treinamento e aplicação de modelos de inteligência artificial para a previsão de ocorrência de câncer em um indivíduo |
| WO2024216391A1 (en) * | 2023-04-19 | 2024-10-24 | Molecular You Corporation | Method of diagnosis and treatment of pancreatic cancer |
| KR20250169643A (ko) * | 2024-05-22 | 2025-12-04 | 주식회사 베르티스 | 췌장암의 진단용 신규 바이오마커 |
Family Cites Families (123)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5660985A (en) | 1990-06-11 | 1997-08-26 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands containing modified nucleotides |
| US20040254101A1 (en) * | 1995-06-06 | 2004-12-16 | Human Genome Sciences, Inc. | Colon specific gene and protein and cancer |
| AU6688598A (en) | 1997-03-07 | 1998-09-22 | University Of Florida | Method for diagnosing and staging prostate cancer |
| US6335170B1 (en) | 1999-02-22 | 2002-01-01 | Torben F. Orntoft | Gene expression in bladder tumors |
| US7090983B1 (en) | 1999-09-10 | 2006-08-15 | Takashi Muramatsu | Methods for detecting early cancer |
| WO2001066690A2 (en) | 2000-03-06 | 2001-09-13 | Smithkline Beecham Corporation | Novel compounds |
| US6596503B1 (en) | 2000-08-18 | 2003-07-22 | East Carolina University | Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof |
| US6631330B1 (en) | 2000-08-21 | 2003-10-07 | Assistance Publique-Hopitaux De Paris (Ap-Hp) | Diagnosis method of inflammatory, fibrotic or cancerous disease using biochemical markers |
| US6576423B2 (en) * | 2000-12-08 | 2003-06-10 | The Board Of Regents Of The University Of Nebraska | Specific mucin expression as a marker for pancreatic cancer |
| IL157872A0 (en) | 2001-03-12 | 2004-03-28 | Monogen Inc | A panel for detecting a generic disease state containing a plurality of probes and using cell-based diagnosis |
| AU2002309583A1 (en) | 2001-04-18 | 2002-11-05 | Protein Desing Labs, Inc. | Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| US7189507B2 (en) | 2001-06-18 | 2007-03-13 | Pdl Biopharma, Inc. | Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
| US7622260B2 (en) | 2001-09-05 | 2009-11-24 | The Brigham And Women's Hospital, Inc. | Diagnostic and prognostic tests |
| AU2002343443A1 (en) | 2001-09-28 | 2003-04-14 | Whitehead Institute For Biomedical Research | Classification of lung carcinomas using gene expression analysis |
| WO2003058201A2 (en) | 2001-12-31 | 2003-07-17 | Quark Biotech, Inc. | Methods for identifying marker genes for cancer |
| EP2261368A1 (en) | 2002-03-13 | 2010-12-15 | Genomic Health, Inc. | Gene expression profiling in biopsied tumor tissues |
| WO2004031411A2 (en) * | 2002-09-30 | 2004-04-15 | Oncotherapy Science, Inc. | Genes and polypeptides relating to human pancreatic cancers |
| US20050260639A1 (en) * | 2002-09-30 | 2005-11-24 | Oncotherapy Science, Inc. | Method for diagnosing pancreatic cancer |
| CA2506066A1 (en) | 2002-11-15 | 2004-06-03 | Genomic Health, Inc. | Gene expression profiling of egfr positive cancer |
| CN1726395A (zh) * | 2002-12-17 | 2006-01-25 | 北京诺赛基因组研究中心有限公司 | 胰腺癌的特异标记 |
| WO2004055519A2 (en) * | 2002-12-17 | 2004-07-01 | Sinogenomax Co. Ltd. | Specific markers for pancreatic cancer |
| EP1573044A4 (en) | 2002-12-18 | 2006-07-05 | Ciphergen Biosystems Inc | SERUM BIOMARKERS IN LUNG CANCER |
| US20050181375A1 (en) | 2003-01-10 | 2005-08-18 | Natasha Aziz | Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer |
| US20040231909A1 (en) | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
| AU2003900747A0 (en) | 2003-02-18 | 2003-03-06 | Garvan Institute Of Medical Research | Diagnosis and treatment of pancreatic cancer |
| CA2516553C (en) | 2003-02-20 | 2013-04-16 | Genomic Health, Inc. | Use of intronic rna to measure gene expression |
| WO2004075713A2 (en) | 2003-02-26 | 2004-09-10 | Mount Sinai Hospital | Multiple marker assay for detection of ovarian cancer |
| WO2004099432A2 (en) | 2003-05-02 | 2004-11-18 | The Johns Hopkins University | Identification of biomarkers for detecting pancreatic cancer |
| CN1852974A (zh) * | 2003-06-09 | 2006-10-25 | 密歇根大学董事会 | 用于治疗和诊断癌症的组合物和方法 |
| KR20060031809A (ko) * | 2003-06-09 | 2006-04-13 | 더 리젠츠 오브 더 유니버시티 오브 미시간 | 암 치료 및 진단용 조성물 및 방법 |
| WO2005039382A2 (en) | 2003-06-24 | 2005-05-06 | Genomic Health | Prediction of likelihood of cancer recurrence |
| EP1644858B1 (en) | 2003-07-10 | 2017-12-06 | Genomic Health, Inc. | Expression profile algorithm and test for cancer prognosis |
| EP1668360A4 (en) | 2003-08-15 | 2007-08-08 | Univ Pittsburgh | MULTI FACTOR CANCER DETECTION TEST |
| US7807392B1 (en) | 2003-09-15 | 2010-10-05 | Celera Corporation | Lung disease targets and uses thereof |
| WO2005043163A2 (en) | 2003-11-04 | 2005-05-12 | Roche Diagnostics Gmbh | Method for distinguishing who classified aml subtypes |
| US20050181451A1 (en) | 2004-02-12 | 2005-08-18 | Bates Harold M. | Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants |
| US7666583B2 (en) | 2004-02-19 | 2010-02-23 | Yale University | Identification of cancer protein biomarkers using proteomic techniques |
| EP1730308A4 (en) | 2004-03-05 | 2008-10-08 | Rosetta Inpharmatics Llc | CLASSIFICATION OF BREAST CANCER PATIENTS USING A COMBINATION OF CLINICAL CRITERIA AND INFORMATIVE SKILLS |
| CA2848463A1 (en) | 2004-04-09 | 2005-10-27 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
| WO2005113798A2 (en) | 2004-04-15 | 2005-12-01 | University Of Florida Research Foundation, Inc. | Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining |
| WO2005103281A2 (en) | 2004-04-26 | 2005-11-03 | Children's Medical Center Corporation | Platelet biomarkers for the detection of disease |
| WO2006022643A1 (en) | 2004-07-26 | 2006-03-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for detecting pancreatic disease |
| KR20070043868A (ko) | 2004-08-02 | 2007-04-25 | 칠드런'즈 메디컬 센터 코포레이션 | 암에 대한 혈소판 바이오마커 |
| JP2006053113A (ja) | 2004-08-16 | 2006-02-23 | Medical Proteoscope Co Ltd | 肺腺癌リンパ節転移診断方法及び診断キット |
| CA3061785A1 (en) | 2004-11-05 | 2006-05-18 | Genomic Health, Inc. | Predicting response to chemotherapy using gene expression markers |
| JP4939425B2 (ja) | 2004-11-05 | 2012-05-23 | ジェノミック ヘルス， インコーポレイテッド | 乳癌の治療反応の予後および予測の分子指標 |
| US7862995B2 (en) | 2004-12-10 | 2011-01-04 | Targeted Molecular Diagnostics | Methods and materials for predicting responsiveness to treatment with dual tyrosine kinase inhibitor |
| US8632983B2 (en) | 2005-04-15 | 2014-01-21 | Van Andel Research Institute | Biomarkers for pancreatic cancer and diagnostic methods |
| US20070099209A1 (en) | 2005-06-13 | 2007-05-03 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| EP1904649A2 (en) | 2005-07-18 | 2008-04-02 | Epigenomics AG | Compositions and methods for cancer diagnostics comprising pan-cancer markers |
| US7521195B1 (en) | 2005-07-21 | 2009-04-21 | Celera Corporation | Lung disease targets and uses thereof |
| WO2007013665A2 (en) | 2005-07-27 | 2007-02-01 | Oncotherapy Science, Inc. | Method of diagnosing small cell lung cancer |
| EP1937837A2 (en) | 2005-07-29 | 2008-07-02 | Siemens Healthcare Diagnostics Inc. | Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies |
| US7582441B1 (en) | 2005-10-17 | 2009-09-01 | Celera Corporation | Methods and compositions for treating and diagnosing disease |
| EP1777523A1 (en) | 2005-10-19 | 2007-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method |
| US8329408B2 (en) | 2005-10-31 | 2012-12-11 | Bayer Healthcare Llc | Methods for prognosis and monitoring cancer therapy |
| KR20080073740A (ko) | 2005-11-10 | 2008-08-11 | 유니버시티 오브 캔터키 | 폐암 진단 검사 |
| US8445198B2 (en) | 2005-12-01 | 2013-05-21 | Medical Prognosis Institute | Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy |
| US8014957B2 (en) | 2005-12-15 | 2011-09-06 | Fred Hutchinson Cancer Research Center | Genes associated with progression and response in chronic myeloid leukemia and uses thereof |
| ES2606015T3 (es) | 2005-12-22 | 2017-03-17 | Abbott Molecular Inc. | Métodos y combinaciones de marcadores para la detección de la predisposición al cáncer de pulmón |
| KR20090003178A (ko) | 2006-01-11 | 2009-01-09 | 게노믹 헬쓰, 인코포레이티드 | 직장결장암 예후에 대한 유전자 발현 마커 |
| AU2007211085A1 (en) | 2006-01-27 | 2007-08-09 | Tripath Imaging, Inc. | Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor |
| CA2641315A1 (en) * | 2006-02-06 | 2007-08-16 | Tethys Bioscience, Inc. | Osteoporosis associated markers and methods of use thereof |
| US20090155799A1 (en) * | 2006-03-02 | 2009-06-18 | Yusuke Nakamura | Methods for diagnosing pancreatic cancer using reg4 protein |
| US7908091B2 (en) | 2006-03-17 | 2011-03-15 | Prometheus Laboratories Inc. | Methods of predicting and monitoring tyrosine kinase inhibitor therapy |
| WO2007123772A2 (en) | 2006-03-31 | 2007-11-01 | Genomic Health, Inc. | Genes involved in estrogen metabolism |
| EP2016394A4 (en) | 2006-04-04 | 2013-04-24 | Singulex Inc | METHOD AND COMPOSITIONS FOR HIGHLY SENSITIVE ANALYSIS OF MARKERS AND DETECTION OF MOLECULES |
| EP2302395B1 (en) | 2006-06-07 | 2015-04-15 | Health Diagnostic Laboratory, Inc. | Markers associated with arteriovascular events and methods of use thereof |
| US20080090258A1 (en) | 2006-06-28 | 2008-04-17 | University Of Pittsburgh -Of The Commonwealth System Of Higher Education | Method and composition for diagnosing endometrial cancer |
| EP2090665A2 (en) | 2006-10-20 | 2009-08-19 | Exiqon A/S | Novel human microRNAs associated with cancer |
| CA2669600A1 (en) | 2006-11-13 | 2008-05-29 | Source Precision Medicine, Inc. D/B/A Source Mdx | Gene expression profiling for identification, monitoring, and treatment of lung cancer |
| WO2008086182A2 (en) | 2007-01-04 | 2008-07-17 | University Of Rochester | Use of gene signatures to design novel cancer treatment regimens |
| US7947447B2 (en) | 2007-01-16 | 2011-05-24 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
| KR100846354B1 (ko) | 2007-03-21 | 2008-07-15 | (주) 프로탄바이오 | 혈청 당단백질부터 분리한 폐암 진단용 마커 |
| WO2008117067A2 (en) * | 2007-03-27 | 2008-10-02 | Carl Arne Krister Borrebaeck | Protein signature/markers for the detection of adenocarcinoma |
| WO2008121340A1 (en) | 2007-03-28 | 2008-10-09 | Vermillion, Inc. | Methods for diagnosing ovarian cancer |
| EP2515116A1 (en) | 2007-05-18 | 2012-10-24 | Duke University | Serum biomarkers for the early detection of lung cancer |
| EP2167976A2 (en) * | 2007-05-29 | 2010-03-31 | President And Fellows Of Harvard College | Molecules involved in regulation of osteoblast activity and osteoclast activity, and methods of use thereof |
| GB0717637D0 (en) | 2007-09-10 | 2007-10-17 | Univ Leiden | Future cardiac event biomarkers |
| US7888051B2 (en) | 2007-09-11 | 2011-02-15 | Cancer Prevention And Cure, Ltd. | Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues |
| US8541183B2 (en) | 2007-09-11 | 2013-09-24 | Cancer Prevention And Cure, Ltd. | Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof |
| US20100267041A1 (en) * | 2007-09-14 | 2010-10-21 | Predictive Biosciences, Inc. | Serial analysis of biomarkers for disease diagnosis |
| WO2009039023A2 (en) | 2007-09-18 | 2009-03-26 | Board Of Regents Of The University Of Texas System | Detection of saliva proteins modulated secondary to ductal carcinoma in situ of the breast |
| EP2227556B1 (en) | 2007-11-19 | 2014-08-27 | Celera Corporation | Lung cancer markers and uses thereof |
| US20090186370A1 (en) | 2008-01-18 | 2009-07-23 | Ogle Matthew F | Diagnostic biomarkers for vascular aneurysm |
| GB0803192D0 (en) | 2008-02-22 | 2008-04-02 | Mubio Products Bv | SCLC biomarker panel |
| US8067178B2 (en) | 2008-03-14 | 2011-11-29 | Genomic Health, Inc. | Gene expression markers for prediction of patient response to chemotherapy |
| RU2011103915A (ru) * | 2008-07-04 | 2012-08-10 | Кабусики Кайся Тосиба (Jp) | Способ и устройство кодирования/декодирования движущегося изображения |
| US20120143805A1 (en) | 2008-09-09 | 2012-06-07 | Somalogic, Inc. | Cancer Biomarkers and Uses Thereof |
| CA3011730C (en) | 2008-09-09 | 2022-05-17 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| US10359425B2 (en) | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| US8580520B2 (en) * | 2008-09-15 | 2013-11-12 | Herlev Hospital | YKL-40 as a marker for gastrointestinal cancers |
| US20100221752A2 (en) | 2008-10-06 | 2010-09-02 | Somalogic, Inc. | Ovarian Cancer Biomarkers and Uses Thereof |
| US20120165217A1 (en) | 2008-10-06 | 2012-06-28 | Somalogic, Inc. | Cancer Biomarkers and Uses Thereof |
| AU2009302537A1 (en) | 2008-10-06 | 2010-04-15 | Somalogic, Inc. | Ovarian cancer biomarkers and uses thereof |
| CA2741117A1 (en) | 2008-10-30 | 2010-05-06 | Centre De Recherche Public De La Sante | Biomarkers for heart failure |
| GB2512153B (en) | 2008-11-17 | 2014-11-12 | Veracyte Inc | Methods and compositions of molecular profiling for disease diagnostics |
| EP2366162A1 (en) | 2008-11-18 | 2011-09-21 | Collabrx, Inc. | Individualized cancer treatment |
| WO2010065940A1 (en) | 2008-12-04 | 2010-06-10 | The Regents Of The University Of California | Materials and methods for determining diagnosis and prognosis of prostate cancer |
| AU2010259022B2 (en) | 2009-06-08 | 2016-05-12 | Singulex, Inc. | Highly sensitive biomarker panels |
| EP2264183B1 (en) | 2009-06-09 | 2016-12-07 | Gendiag.exe, S.L. | Risk markers for cardiovascular disease |
| CA2765145A1 (en) | 2009-06-15 | 2010-12-23 | Cardiodx, Inc. | Determination of coronary artery disease risk |
| EP2467719A4 (en) | 2009-08-19 | 2013-01-09 | MARKER RECOGNITION FOR CHARACTERIZING THE RISK OF CARDIOVASCULAR DISORDERS OR RESULTS COMPLICATED THEREOF | |
| US20120178111A1 (en) | 2009-09-23 | 2012-07-12 | Diamandis Eleftherios P | Methods and compositions for the detection of lung cancers |
| US10024857B2 (en) * | 2009-10-01 | 2018-07-17 | Med-Life Discoveries Lp | Serum-based biomarkers of pancreatic cancer and uses thereof for disease detection and diagnosis |
| EP2491396A4 (en) | 2009-10-22 | 2013-04-17 | Univ California | INVESTIGATION OF A FIXED TUMOR LOAD |
| JP2013509588A (ja) | 2009-10-29 | 2013-03-14 | テシス バイオサイエンス， インコーポレイテッド | ２型糖尿病の予防に対して一貫した改善をもたらすタンパク質バイオマーカーおよび脂質代謝物バイオマーカー |
| CA2782620A1 (en) * | 2009-12-01 | 2011-06-09 | Compendia Bioscience, Inc. | Classification of cancers |
| WO2011072177A2 (en) | 2009-12-09 | 2011-06-16 | Aviir, Inc. | Biomarker assay for diagnosis and classification of cardiovascular disease |
| CA3256492A1 (en) | 2010-01-11 | 2025-11-29 | Genomic Health Inc | Method to use gene expression to determine likelihood of clinical outcome of renal cancer |
| US9404926B2 (en) | 2010-01-29 | 2016-08-02 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Immune gene signatures in cancer |
| JP6114035B2 (ja) | 2010-02-10 | 2017-04-12 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 肺癌検出用唾液バイオマーカー |
| WO2011100472A1 (en) | 2010-02-10 | 2011-08-18 | The Regents Of The University Of California | Salivary transcriptomic and proteomic biomarkers for breast cancer detection |
| CN103237901B (zh) | 2010-03-01 | 2016-08-03 | 卡里斯生命科学瑞士控股有限责任公司 | 用于治疗诊断的生物标志物 |
| CA2795776A1 (en) | 2010-04-06 | 2011-10-13 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Circulating biomarkers for disease |
| MX355020B (es) | 2010-07-09 | 2018-04-02 | Somalogic Inc | Biomarcadores de cancer de pulmon y usos de los mismos. |
| JP5931874B2 (ja) | 2010-08-13 | 2016-06-08 | ソマロジック・インコーポレーテッド | 膵癌バイオマーカーおよびその使用 |
| AU2011312491B2 (en) | 2010-09-27 | 2015-06-04 | Somalogic, Inc. | Mesothelioma biomarkers and uses thereof |
| AU2012249288C1 (en) | 2011-04-29 | 2017-12-21 | Lung Cancer Proteomics Llc | Methods of identification and diagnosis of lung diseases using classification systems and kits thereof |
| CA2843756A1 (en) | 2011-08-22 | 2013-02-28 | Somalogic, Inc. | Renal cell carcinoma biomarkers and uses thereof |
| SG10201607331WA (en) | 2011-09-30 | 2016-11-29 | Somalogic Inc | Cardiovascular risk event prediction and uses thereof |
| JP6124986B2 (ja) | 2012-03-19 | 2017-05-10 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． | 拡張期心不全を処置するための増殖分化因子（ｇｄｆ） |
| BR112016010165A2 (pt) | 2013-11-21 | 2017-12-05 | Somalogic Inc | composições de nucleotídeos modificados de citidina-5-carboxamida e métodos relacionados às mesmas |
-
2011
- 2011-08-12 JP JP2013525961A patent/JP5931874B2/ja not_active Expired - Fee Related
- 2011-08-12 WO PCT/US2011/047570 patent/WO2012021795A2/en not_active Ceased
- 2011-08-12 CN CN201180049408.2A patent/CN103415624B/zh not_active Expired - Fee Related
- 2011-08-12 BR BR112013003391A patent/BR112013003391B8/pt not_active IP Right Cessation
- 2011-08-12 MX MX2013001042A patent/MX341517B/es active IP Right Grant
- 2011-08-12 CN CN201610479435.8A patent/CN106198980B/zh not_active Expired - Fee Related
- 2011-08-12 AU AU2011289284A patent/AU2011289284B2/en not_active Ceased
- 2011-08-12 EP EP11817097.6A patent/EP2603622A4/en not_active Withdrawn
- 2011-08-12 KR KR1020137003215A patent/KR101857462B1/ko not_active Expired - Fee Related
- 2011-08-12 SG SG10201710447QA patent/SG10201710447QA/en unknown
- 2011-08-12 MX MX2016010635A patent/MX350533B/es unknown
- 2011-08-12 SG SG2014007454A patent/SG2014007454A/en unknown
- 2011-08-12 US US13/208,903 patent/US20120040861A1/en not_active Abandoned
- 2011-08-12 SG SG2013002456A patent/SG187045A1/en unknown
- 2011-08-12 CA CA2804857A patent/CA2804857C/en active Active
-
2012
- 2012-12-30 IL IL224014A patent/IL224014A/en active IP Right Grant
-
2013
- 2013-09-06 US US14/020,334 patent/US20140073522A1/en not_active Abandoned
-
2015
- 2015-05-28 AU AU2015202907A patent/AU2015202907B2/en not_active Ceased
-
2016
- 2016-12-06 AU AU2016269430A patent/AU2016269430B2/en not_active Ceased
-
2017
- 2017-08-17 US US15/679,643 patent/US11041866B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013541697A5 (enExample) | ||
| JP2013532295A5 (enExample) | ||
| Lobo et al. | Identification and validation model for informative liquid biopsy-based microRNA biomarkers: insights from germ cell tumor in vitro, in vivo and patient-derived data | |
| Martini et al. | Circulating tumor cells in pancreatic cancer: current perspectives | |
| JP2012502281A5 (enExample) | ||
| Théry | Diagnosis by extracellular vesicles | |
| KR102111624B1 (ko) | 심혈관 위험 사건 예측 및 그것의 용도 | |
| Fisic et al. | The Role of IL‐6, 8, and 10, sTNFr, CRP, and pancreatic elastase in the prediction of systemic complications in patients with acute pancreatitis | |
| Matuszczak et al. | A liquid biopsy in bladder cancer—The current landscape in urinary biomarkers | |
| Das et al. | ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy | |
| Fullerton et al. | Helicobacter pylori and lung function, asthma, atopy and allergic disease—a population-based cross-sectional study in adults | |
| Verschuren et al. | Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLD | |
| Brezgyte et al. | Non-invasive biomarkers for earlier detection of pancreatic cancer—a comprehensive review | |
| Singh et al. | Non-invasive biomarkers for celiac disease | |
| JP6018923B2 (ja) | 敗血症の予後の予測方法 | |
| Palone et al. | Fecal HMGB1 reveals microscopic inflammation in adult and pediatric patients with inflammatory bowel disease in clinical and endoscopic remission | |
| Coco et al. | Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy | |
| ES2868077T3 (es) | Diagnóstico mediante células tumorales circulantes para biomarcadores predictivos de la resistencia a las terapias selectivas del receptor de andrógenos (RA) | |
| JP2017530356A5 (enExample) | ||
| Berezin et al. | Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation | |
| Yee et al. | Extracellular vesicles as potential biomarkers for early detection and diagnosis of pancreatic cancer | |
| de Nooijer et al. | Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19 | |
| US20220091123A1 (en) | Circulating tumor cell diagnostics for identification of resistance to androgen receptor targeted therapies | |
| Fiedorczuk et al. | Investigating the role of serum and plasma IL-6, IL-8, IL-10, TNF-alpha, CRP, and S100B concentrations in obstructive sleep apnea diagnosis | |
| Jung et al. | Surface proteome of plasma extracellular vesicles as biomarkers for pneumonia and acute exacerbation of chronic obstructive pulmonary disease |